All Stories

  1. Scalp Melanoma in a Young Patient With Systemic Sarcoidosis: Multidisciplinary Approach
  2. Ultra‐high frequency ultrasound predicts baricitinib response in alopecia areata: Towards personalized treatment
  3. Effectiveness and safety of baricitinib in severe alopecia areata: 48‐week results
  4. Efficacy and safety of a medical device based on hyaluronic acid and amino acids for the topical treatment of hard-to-heal skin ulcers: a pilot clinical trial
  5. Upadacitinib dose adjustment in moderate‐to‐severe atopic dermatitis: insights from a multicenter real‐world study
  6. Assessing the burden of dermatological diseases on work life from a gender perspective
  7. Correlation Between Ultra‐High Frequency Ultrasound (UHFUS) and Histological Features of Typical Lesions in Hidradenitis Suppurativa
  8. Prurigo Nodularis at Ultra-High-Frequency Ultrasound
  9. Foliage Intense Filler, Affects Nasolabial Folds Wrinkles: Effectiveness and Safety by Prospective Comparative Study
  10. Recalcitrant Grover's disease treated with dupilumab: two long‐term cases and review of the literature
  11. Clinical impact of zinc oxide compression bandaging in chronic venous disease assessed with ultrasonography and trans-epidermal water loss – preliminary observations
  12. Incidence of therapy switch in patients with moderate to severe palmoplantar psoriasis treated with anti-IL 17 and anti-IL 23 monoclonal antibodies: a retrospective observational study
  13. Ultra-High Frequency Ultrasound (UHFUS) Features of Pyoderma Gangrenosum, Venous Leg Ulcers, and Acute Ulcerative Lesions
  14. High-Frequency and Ultra-High-Frequency Ultrasound in Dermatologic Diseases and Aesthetic Medicine
  15. Correlation between skin cancer and therapy with anti-IL monoclonal antibodies in patients affected by moderate-to-severe psoriasis: an observational monocentric study
  16. Tirbanibulin in actinic keratosis treatment: evaluation of effectiveness, safety and patients’ satisfaction in a comparison with cryotherapy
  17. High-Frequency and Ultra-High-Frequency Ultrasound in Dermatologic Diseases and Aesthetic Medicine
  18. Effectiveness of wide local excision and secondary intention healing in hidradenitis suppurativa: a single-centre study on quality of life and mental health outcomes
  19. Paradoxical Eczematous Eruptions in Patients with Psoriasis Treated with Biological Therapy
  20. Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study
  21. Cord Blood Serum Levels of IL-31 and CCL17, Cutaneous Markers, and Development of Atopic Dermatitis
  22. Real‐life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24‐week Italian study
  23. Interleukin‐1 family cytokines and soluble receptors in hidradenitis suppurativa
  24. Evaluation of post-surgical complications of hidradenitis suppurativa lesions explored with presurgical ultra-high frequency ultrasound mapping
  25. Melanocytic nevi changes during pregnancy: What to do?
  26. Effectiveness of guselkumab in patients with facial and/or genital psoriasis: Interim analysis results at Week 12 from the GULLIVER study
  27. Risankizumab as a Therapeutic Approach for Recalcitrant Pyoderma Gangrenosum
  28. Switch from adalimumab to brodalumab as a possible trigger factor for the onset of pyoderma gangrenosum
  29. Clinical Features and Response to Treatment in Elderly Subjects Affected by Hidradenitis Suppurativa: A Cohort Study
  30. International Hidradenitis Suppurativa Severity Scoring System (IHS4) as a holistic measure of hidradenitis suppurativa disease severity compared with Hurley staging: A post hoc analysis of the SUNRISE and SUNSHINE phase 3 trials of secukinumab
  31. Fluorescence-Based Evaluation of Bacterial Load in Perilesional Skin: A Comparison Between Short Stretch Bandage and Zinc Oxide Bandage
  32. The Role of Ultra-High-Frequency Ultrasound in Pyoderma Gangrenosum: New Insights in Pathophysiology and Diagnosis
  33. Ultra-High-Frequency Ultrasound as an Innovative Imaging Evaluation of Hyaluronic Acid Filler in Nasolabial Folds
  34. Ultra-High Frequency UltraSound (UHFUS) Assessment of Barrier Function in Moderate-to-Severe Atopic Dermatitis during Dupilumab Treatment
  35. Assessment and Monitoring of Nail Psoriasis with Ultra-High Frequency Ultrasound: Preliminary Results
  36. The diagnosis, management and prevention of intertrigo in adults: a review
  37. Pso-Reg: a web registry for psoriasis in real life
  38. Compression Therapy in Dermatology
  39. An Integrated Systemic and Local Wound Management in Recalcitrant Pyoderma Gangrenosum
  40. Pyoderma Gangrenosum in a Patient With Dubowitz Syndrome: a New Comorbidity?
  41. A Phase IIIb, Multicentre, Interventional, Randomised, Placebo‐Controlled Clinical Trial Investigating the Efficacy and Safety of Guselkumab for the Treatment of Nonpustular Palmoplantar Psoriasis (G‐PLUS)
  42. Serum Amyloid A: A Potential New Marker of Severity in Hidradenitis Suppurativa
  43. National Information Campaign Revealed Disease Characteristic and Burden in Adult Patients Suffering from Atopic Dermatitis
  44. Secukinumab demonstrated sustained retention, effectiveness and safety in a real‐world setting in patients with moderate‐to‐severe plaque psoriasis: long‐term results from an interim analysis of the SERENA study
  45. The Role of Autoflorescence Imaging Device in the Evaluation of Bacteria Burden Control
  46. The Genetic Basis of Dormancy and Awakening in Cutaneous Metastatic Melanoma
  47. Parasites causing cutaneous wounds: Theory and practice from a dermatological point of view
  48. Impact of psychiatric comorbidities in psoriasis, hidradenitis suppurativa and atopic dermatitis: The importance of a psychodermatological approach
  49. Oral ivermectin: a feasible alternative to topical therapy of genital scabies
  50. Adherence and Persistence to Biological Drugs for Psoriasis: Systematic Review with Meta-Analysis
  51. A real‐life experience as a proof of Guselkumab effectiveness and safety in patients with moderate to severe psoriasis
  52. Family history of psoriasis: a novel protective factor for therapy switch in patients treated with Secukinumab or Ixekizumab
  53. Palliative Management of a Recurrent Destructive Cutaneous Squamous Cell Carcinoma of the Scalp With Brain Exposure
  54. Blue light emission in the management of hard-to-heal wounds
  55. Local Management of Malignant and Unresectable Fungating Wounds: PEBO Assessment
  56. Effect of dupilumab on genital condylomata: a case report
  57. Echoentomography for Assessing Braconid Parasitization on Soft-Bodied Tephritid Hosts
  58. Umbilical giant condyloma acuminatum
  59. Unusual presentation of angiolymphoid hyperplasia with eosinophilia treated with intralesional and topic corticosteroid combination therapy
  60. Ultra-high-frequency ultrasound monitoring of melanomas arising in congenital melanocytic nevi: a case series
  61. Risk factors in pediatric melanoma: a retrospective study of 39 cases
  62. Ultrasound‐guided injection of intralesional steroids in acute hidradenitis suppurativa lesions: A prospective study
  63. Seborrheic keratosis-like melanoma: a diagnostic challenge
  64. Definition of treatment goals in terms of clinician-reported disease severity and patient-reported outcomes in moderate-to-severe adult atopic dermatitis: a systematic review
  65. Evaluation of neutrophil extracellular trap deregulated formation in pyoderma gangrenosum
  66. The Association Between pH and Fluorescence as Noninvasive Diagnostic Tools in Chronic Wounds
  67. Ultra‐high‐frequency ultrasound and machine learning approaches for the differential diagnosis of melanocytic lesions
  68. Systemic antibiotics in hidradenitis suppurativa: efficacy and effects of body mass index and smoking pack‐year on the response to therapy
  69. Ultra‐high‐frequency ultrasound monitoring of plaque psoriasis during ixekizumab treatment
  70. Wound Dehiscence After Achilles Tendon Trauma and Repair: Treatment With Ultraportable Negative Pressure Wound Therapy and Compression Therapy
  71. The potential role of propranolol in incontinentia pigmenti
  72. Improvement of severe facial seborrheic dermatitis following low-dose isotretinoin therapy
  73. Gynecomastia following isotretinoin treatment: a rare endocrine side effect
  74. 5% Lidocaine Hydrochloride Cream for Wound Pain Relief: A Multicentre Observational Study
  75. Surrounding skin management in venous leg ulcers: A systematic review
  76. Isotretinoin-triggered acne fulminans: a rare, disabling occurrence
  77. Dermatoscopic and ultra‐high frequency ultrasound evaluation in cutaneous postradiation angiosarcoma
  78. PG‐TIME : A practical approach to the clinical management of pyoderma gangrenosum
  79. <p>Using Skin Bioengineering to Highlight How Weight and Diabetes Mellitus Modify the Skin in the Lower Limbs of Super-Obese Patients</p>
  80. Triticum vulgare Extract Modulates Protein-Kinase B and Matrix Metalloproteinases 9 Protein Expression in BV-2 Cells: Bioactivity on Inflammatory Pathway Associated with Molecular Mechanism Wound Healing
  81. Atypical Ulcers: Diagnosis and Management
  82. A giant annular rash in a woodman: the many faces of erythema chronicum migrans
  83. Itch in Chronic Wounds: Pathophysiology, Impact, and Management
  84. Biomodulation induced by fluorescent light energy versus standard of care in venous leg ulcers: a retrospective study
  85. Intraoral Ultra‐High Frequency Ultrasound study of oral lichen planus: A pictorial review
  86. Tuscan consensus on the diagnosis and treatment of hidradenitis suppurativa
  87. Topical purified omental lipid formulations in the prevention of skin ulcers: a narrative review
  88. Potential role of serum amyloid A in hidradenitis suppurativa
  89. Breast surgeons dealing with Munchausen syndrome: A self‐induced necrotic phlegmon of the breast treated with surgery, negative pressure and epidermal fractional skin grafting
  90. Current therapeutic paradigm in pediatric atopic dermatitis: Practical guidance from a national expert panel
  91. Tuscan consensus on the use of UVBnb phototherapy in the treatment of psoriasis
  92. Is it really just a small world?
  93. Sex‐related differences of clinical features in hidradenitis suppurativa: analysis of an Italian‐based cohort
  94. Necrotoxic spider bite: a successful noninvasive wound management
  95. Risankizumab for the treatment of moderate to severe psoriasis
  96. Evaluation of fluorescence biomodulation in the real-life management of chronic wounds: the EUREKA trial
  97. Enhancing daily practice through knowledge sharing
  98. Comparison of clinical and ultrasound scores in patients with hidradenitis suppurativa: results from an Italian ultrasound working group
  99. Cell salvage in acute and chronic wounds: a potential treatment strategy. Experimental data and early clinical results
  100. Acne fulminans associated with lymecycline intake: a case report
  101. Physician-patient communication and patient-reported outcomes in the actinic keratosis treatment adherence initiative (AK-TRAIN): a multicenter, prospective, real-life study of treatment satisfaction, quality of life and adherence to topical field-directe
  102. Elderly psoriatic patients under biological therapies: an Italian experience
  103. Catching the vulnologists around the globe
  104. Towards an international language for incontinence-associated dermatitis (IAD): design and evaluation of psychometric properties of the Ghent Global IAD Categorization Tool (GLOBIAD) in 30 countries
  105. Long-Term Outcome of Adalimumab in a Young Girl with Hidradenitis Suppurativa
  106. The Hidradenitis Suppurativa (HS) “Multidisciplinary Unit”: a rationale and practical proposal for an organised clinical approach
  107. Optimising collaboration in science and clinical practice
  108. Scanning the Immunopathogenesis of Psoriasis
  109. Intralesional Diode Laser 1064 nm for the Treatment of Hidradenitis Suppurativa: A Report of Twenty Patients
  110. Determination of salivary α-amylase and cortisol in psoriatic subjects undergoing the Trier Social Stress Test
  111. Hidradenitis Suppurativa Associated with Down Syndrome Is Characterized by Early Age at Diagnosis
  112. Sensors and Biosensors for C-Reactive Protein, Temperature and pH, and Their Applications for Monitoring Wound Healing: A Review
  113. EUREKA study – the evaluation of real-life use of a biophotonic system in chronic wound management: an interim analysis
  114. A new class of biologic agents facing the therapeutic paradigm in psoriasis: anti-IL-23 agents.
  115. Treatment of psoriasis with topical agents: Recommendations from a Tuscany Consensus
  116. Biomarkers—an unmet need in wound care
  117. Evaluation of osteopontin expression in chronic wounds: a potential prognostic and therapeutic biomarker
  118. Biomarkers for psoriasis skin lesions
  119. The management of moderate-to-severe chronic plaque psoriasis
  120. Introducing the new WUWHS executive and editorial board
  121. Spotlight on dupilumab in the treatment of atopic dermatitis: design, development, and potential place in therapy
  122. Temperature and pH sensors based on graphenic materials
  123. Association between HCV infection and cutaneous-mucosal lichen planus: an update
  124. TSLP-activated dendritic cells induce human T follicular helper cell differentiation through OX40-ligand
  125. Retroauricular angiolymphoid hyperplasia with eosinophilia: sustained long-term remission following treatment with corticosteroids
  126. Tuscan consensus on the diagnosis, treatment and follow-up of moderate-to-severe psoriasis
  127. Primary cutaneous diffuse large B-cell lymphoma presenting as chronic non-healing ulcer
  128. Temperature- and pH-sensitive wearable materials for monitoring foot ulcers
  129. Optimizing acitretin use in patients with plaque psoriasis
  130. Contact dermatitis in patients with chronic leg ulcers: a common and neglected problem: a review 2000–2015
  131. No meaningful association between suicidal behavior and the use of IL-17A-neutralizing or IL-17RA-blocking agents
  132. Epidermal skin grafting in vitiligo: a pilot study
  133. Use of advanced technologies across the wound care spectrum: prologue
  134. Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
  135. Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis
  136. The world of wounds comes together
  137. Crosstalk between skin inflammation and adipose tissue-derived products: pathogenic evidence linking psoriasis to increased adiposity
  138. Small molecules and antibodies for the treatment of psoriasis: a patent review (2010–2015)
  139. Recommendations for the management of biofilm: a consensus document
  140. A revolutionary therapeutic approach for psoriasis: bispecific biological agents
  141. Optimizing Technology Use for Chronic Lower-Extremity Wound Healing
  142. A D-optimal design to model the performances of dressings and devices for negative pressure wound therapy
  143. Difficult-to-heal wounds of mixed arterial/venous and venous etiology: a cost-effectiveness analysis of extracellular matrix
  144. What's new: Management of venous leg ulcers
  145. What's new: Management of venous leg ulcers
  146. Erratum: Erratum: Dynamic markers based on blood perfusion fluctuations for selecting skin melanocytic lesions for biopsy
  147. The use of a collagen matrix in hard-to-heal venous leg ulcers
  148. Skin Physiology of the Neonate and Infant: Clinical Implications
  149. Dynamic markers based on blood perfusion fluctuations for selecting skin melanocytic lesions for biopsy
  150. Hidradenitis Suppurativa and Wound Management
  151. Biologic drugs in wound management
  152. Clinical evaluation of the efficacy and safety of a medical device in various forms containing Triticum vulgare for the treatment of venous leg ulcers – a randomized pilot study
  153. Fractional epidermal skin grafting
  154. The role of biomedical sensors in wound healing
  155. Atrophie Blanche
  156. Cryoglobulinemia
  157. SWAN-iCare : prise en charge des plaies de pied diabétique par pression négative et monitoring à distance de la cicatrisation
  158. 24thAnnual Meeting of the European Tissue Repair Society
  159. Quantitative Evaluation of Maceration in Venous Leg Ulcers by Transepidermal Water Loss (TEWL) Measurement
  160. Chronic wound management and research
  161. Physical Therapy in Wound Healing, Edema, and Urinary Incontinence
  162. Livedoid vasculopathy: An in-depth analysis using a modified Delphi approach
  163. Introduction
  164. Cutaneous ulcers associated with hydroxyurea therapy
  165. Dear readers
  166. Cutaneous foetal injuries related to amniocentesis
  167. Improvement of Periulcer Skin Condition in Venous Leg Ulcer Patients
  168. SWAN-iCare: A smart wearable and autonomous negative pressure device for wound monitoring and therapy
  169. Use of diagnostics in wound management
  170. Efficacy of Adalimumab for the Treatment of Refractory Paediatric Acrodermatitis Continua of Hallopeau
  171. Measurements in Wound Healing
  172. A temperature sensor based on a MWCNT/SEBS nanocomposite
  173. Skin and Vascular Assessments
  174. Skin temperature monitoring by a wireless sensor
  175. Classification of Wounds at Risk and Their Antimicrobial Treatment with Polihexanide: A Practice-Oriented Expert Recommendation
  176. Evaluation of the Efficacy and Tolerability of a Solution Containing Propyl Betaine and Polihexanide for Wound Irrigation
  177. Dilemmas in measuring and using pressure ulcer prevalence and incidence: an international consensus
  178. Ibuprofen slow-release foam dressing reduces wound pain in painful exuding wounds: Preliminary findings from an international real-life study
  179. Efficacy and tolerance of a hydrocolloid dressing containing hyaluronic acid for the treatment of leg ulcers of venous or mixed origin
  180. Clinical significance of cutaneous proteoglycan (mucin) infiltration in patients with mitral valve prolapse
  181. Amelogenin, an extracellular matrix protein, in the treatment of venous leg ulcers and other hard-to-heal wounds: Experimental and clinical evidence  ||FREE PAPER||
  182. Use of Nanotechnology-Designed Footsock in the Management of Preulcerative Conditions in the Diabetic Foot: Results of a Single, Blind Randomized Study
  183. Dressing‐related pain in patients with chronic wounds: an international patient perspective
  184. Hip fracture and pressure ulcers – the Pan-European Pressure Ulcer Study – intrinsic and extrinsic risk factors
  185. Hydroxyurea-Induced Leg Ulcers Treated With a Protease-Modulating Matrix
  186. Wound Assessment by 3-Dimensional Laser Scanning
  187. Improvement of Idiopathic Pyoderma Gangrenosum During Treatment With Anti-Tumor Necrosis Factor Alfa Monoclonal Antibody
  188. OASIS�wound matrix versus Hyaloskin�in the treatment of difficult-to-heal wounds of mixed arterial/venous aetiology
  189. Prevention and management of pressure ulcers
  190. Microcirculation - a Blarney Stone to Wound Healing
  191. The effect of amelogenins (Xelma™) on hard-to-heal venous leg ulcers
  192. Cutaneous Tissue Engineering and Lower Extremity Wounds (Part 2)
  193. The silver-releasing foam dressing, Contreet Foam, promotes faster healing of critically colonised venous leg ulcers: a randomised, controlled trial
  194. Wound bed preparation and a brief history of TIME
  195. Semiquantitative Analysis of the Histopathological Features of the Neuropathic Foot Ulcer: Effects of pressure relief
  196. Angiogenesis and nerve regeneration in a model of human skin equivalent transplant
  197. Wound bed preparation: a systematic approach to wound management
  198. Sodium carboxyl-methyl-cellulose dressings in the management of deep ulcerations of diabetic foot
  199. Hardness of Plantar Skin in Diabetic Neuropathic Feet
  200. Use of a durometer to measure the degree of skin induration in lipodermatosclerosis
  201. The effect of topical nitroglycerin on transcutaneous oxygen